Oligosaccharide-protein conjugates as vaccine candidates against bacteria.
Pozsgay
V
V
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-2720, USA.
D000595:Amino Acid Sequence; D000818:Animals; D016667:Bacterial Capsules / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D001426:Bacterial Proteins / Q000737:chemistry / Q000276:immunology; D001428:Bacterial Vaccines / Q000737:chemistry* / Q000276:immunology; D002240:Carbohydrate Sequence; D003911:Dextrans / Q000138:chemical synthesis / Q000737:chemistry / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009844:Oligosaccharides / Q000737:chemistry* / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000737:chemistry* / Q000276:immunology*; D011506:Proteins / Q000737:chemistry* / Q000276:immunology; D018074:Vaccines, Conjugate / Q000737:chemistry* / Q000276:immunology
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D003911:Dextrans; D009844:Oligosaccharides; D011135:Polysaccharides, Bacterial; D011506:Proteins; D018074:Vaccines, Conjugate